Orient Pharma Co., Ltd. (TPEX:4166)
Orient Pharma Statistics
Total Valuation
Orient Pharma has a market cap or net worth of TWD 5.73 billion. The enterprise value is 5.95 billion.
Market Cap | 5.73B |
Enterprise Value | 5.95B |
Important Dates
The last earnings date was Wednesday, August 13, 2025.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Orient Pharma has 223.04 million shares outstanding. The number of shares has decreased by -1.00% in one year.
Current Share Class | 223.04M |
Shares Outstanding | 223.04M |
Shares Change (YoY) | -1.00% |
Shares Change (QoQ) | +5.22% |
Owned by Insiders (%) | 2.08% |
Owned by Institutions (%) | n/a |
Float | 35.22M |
Valuation Ratios
The trailing PE ratio is 71.60.
PE Ratio | 71.60 |
Forward PE | n/a |
PS Ratio | 4.54 |
PB Ratio | 3.09 |
P/TBV Ratio | 4.05 |
P/FCF Ratio | 24.45 |
P/OCF Ratio | 22.51 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.43, with an EV/FCF ratio of 25.39.
EV / Earnings | 74.68 |
EV / Sales | 4.72 |
EV / EBITDA | 21.43 |
EV / EBIT | 41.24 |
EV / FCF | 25.39 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.76 |
Quick Ratio | 0.97 |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.56 |
Debt / FCF | 1.85 |
Interest Coverage | 11.70 |
Financial Efficiency
Return on equity (ROE) is 4.39% and return on invested capital (ROIC) is 3.82%.
Return on Equity (ROE) | 4.39% |
Return on Assets (ROA) | 3.50% |
Return on Invested Capital (ROIC) | 3.82% |
Return on Capital Employed (ROCE) | 6.96% |
Revenue Per Employee | 7.30M |
Profits Per Employee | 460,740 |
Employee Count | 173 |
Asset Turnover | 0.49 |
Inventory Turnover | 1.99 |
Taxes
In the past 12 months, Orient Pharma has paid 44.97 million in taxes.
Income Tax | 44.97M |
Effective Tax Rate | 36.07% |
Stock Price Statistics
The stock price has decreased by -2.10% in the last 52 weeks. The beta is -0.02, so Orient Pharma's price volatility has been lower than the market average.
Beta (5Y) | -0.02 |
52-Week Price Change | -2.10% |
50-Day Moving Average | 32.46 |
200-Day Moving Average | 34.57 |
Relative Strength Index (RSI) | 37.83 |
Average Volume (20 Days) | 560,070 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Orient Pharma had revenue of TWD 1.26 billion and earned 79.71 million in profits. Earnings per share was 0.36.
Revenue | 1.26B |
Gross Profit | 664.60M |
Operating Income | 144.34M |
Pretax Income | 124.68M |
Net Income | 79.71M |
EBITDA | 258.14M |
EBIT | 144.34M |
Earnings Per Share (EPS) | 0.36 |
Balance Sheet
The company has 212.58 million in cash and 432.98 million in debt, giving a net cash position of -220.41 million or -0.99 per share.
Cash & Cash Equivalents | 212.58M |
Total Debt | 432.98M |
Net Cash | -220.41M |
Net Cash Per Share | -0.99 |
Equity (Book Value) | 1.86B |
Book Value Per Share | 7.91 |
Working Capital | 361.43M |
Cash Flow
In the last 12 months, operating cash flow was 254.60 million and capital expenditures -20.16 million, giving a free cash flow of 234.44 million.
Operating Cash Flow | 254.60M |
Capital Expenditures | -20.16M |
Free Cash Flow | 234.44M |
FCF Per Share | 1.05 |
Margins
Gross margin is 52.65%, with operating and profit margins of 11.43% and 6.31%.
Gross Margin | 52.65% |
Operating Margin | 11.43% |
Pretax Margin | 9.88% |
Profit Margin | 6.31% |
EBITDA Margin | 20.45% |
EBIT Margin | 11.43% |
FCF Margin | 18.57% |
Dividends & Yields
Orient Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 1.00% |
Shareholder Yield | n/a |
Earnings Yield | 1.39% |
FCF Yield | 4.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on May 23, 2016. It was a reverse split with a ratio of 0.6500936135.
Last Split Date | May 23, 2016 |
Split Type | Reverse |
Split Ratio | 0.6500936135 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 7 |